A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

Clinical trial NCT05358717 · COMPLETED

Trial details

NCT number: NCT05358717
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2022-06-03
Primary completion: 2025-02-07
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.